We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Trial of Preoperative Skin Preparation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02530541
Recruitment Status : Completed
First Posted : August 21, 2015
Last Update Posted : August 21, 2015
Information provided by (Responsible Party):

Study Description
Brief Summary:
Pilot study to evaluate and compare activity of preoperative preparation with comparator

Condition or disease Intervention/treatment Phase
Healthy Drug: CHG Phase 1 Phase 2

Detailed Description:
Evaluate and compare similar preoperative surgical preparations in healthy volunteers. Various application times were evaluated. Efficacy was assess using TFM criteria.

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 67 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Pilot Trial Assessment of the Antimicrobial Efficacy of Medline 2% CHG Cloth Preoperative Skin Preparation
Study Start Date : April 2014
Primary Completion Date : July 2014
Study Completion Date : May 2015

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: CHG 1 min
1 min application time
Drug: CHG
Varied application times
Other Name: Chlorhexidine Gluconate
Experimental: CHG 2 min
2 min application time
Drug: CHG
Varied application times
Other Name: Chlorhexidine Gluconate
Active Comparator: Comparator CHG
Marketed CHG
Drug: CHG
Varied application times
Other Name: Chlorhexidine Gluconate

Outcome Measures

Primary Outcome Measures :
  1. Log Reduction of Bacterial Flora on the Abdomen and Groin [ Time Frame: 10 min, 6 hr and 8 hr ]
    Evaluate the Log Reduction of normal flora at various timepoints

Secondary Outcome Measures :
  1. Adverse Events [ Time Frame: 10 min, 6 hr and 8 hr ]
    Compare the percent of treatment related adverse events

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy
  • No dermatological conditions

Exclusion Criteria:

  • Sensitivity to CHG
  • Sensitivity to natural latex rubber or adhesive skin products
More Information

Responsible Party: Medline Industries
ClinicalTrials.gov Identifier: NCT02530541     History of Changes
Other Study ID Numbers: R14-015
First Posted: August 21, 2015    Key Record Dates
Last Update Posted: August 21, 2015
Last Verified: August 2015

Additional relevant MeSH terms:
Chlorhexidine gluconate
Anti-Infective Agents, Local
Anti-Infective Agents
Dermatologic Agents